Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7439090 | 0.98 | SIGMAR1 (0.63) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| SCHEMBL7440692 | 0.95 | SIGMAR1 (0.62) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| SCHEMBL7429357 | 0.90 | SIGMAR1 (0.56) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| SCHEMBL7432683 | 0.89 | SIGMAR1 (0.59) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| Hydrochloric Acid SCHEMBL7430264 | 0.89 | SIGMAR1 (0.55) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| SCHEMBL7438989 | 0.89 | SIGMAR1 (0.59) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| SCHEMBL7437046 | 0.86 | SIGMAR1 (0.55) | SIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7435436 | 0.85 | SIGMAR1 (0.54) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| Fumaric Acid SCHEMBL7430224 | 0.84 | FDPS (0.52) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS | |
| Maleic Acid SCHEMBL7430214 | 0.84 | FDPS (0.52) | SIGMAR1SLC6A2SLC6A4SLC6A3FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559569-A1 | Central nervous system antiischemic agents | Bristol-Myers Squibb Company (US) | 1993-09-08 | — | — | EP | claimed |